Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON29265
NL-OMON29265
Not yet recruiting
Not Applicable

Arterial Reperfusion or Portal Reperfusion First in Liver Transplantation usingDonation after Circulatory Death donors

Erasmus MC Rotterdam0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsiverTransplantationDonation after Circulatory Death (DCD)Biliary ComplicationsHemodynamic StabilityEarly Allograft Disfunction (EAD)LeverTransplantatieDonatie na Circulatie ArrestGalweg ComplicatiesHemodynamische stabiliteitVroege Transplantaatfunctie

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
iverTransplantationDonation after Circulatory Death (DCD)Biliary ComplicationsHemodynamic StabilityEarly Allograft Disfunction (EAD)LeverTransplantatieDonatie na Circulatie ArrestGalweg ComplicatiesHemodynamische stabiliteitVroege Transplantaatfunctie
Sponsor
Erasmus MC Rotterdam
Enrollment
150
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

  1. Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - An analysis of the national registry. J Hepatol. 2011 Oct;55(4):808-13. 2. Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg. 2011 Apr;251(4):743-8. 3. Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011 Feb;253(2):259-64. 4. Farid WR, de Jonge J, Slieker JC, Zondervan PE, Thomeer MG, Metselaar HJ, et al. The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. Am J Transplant. 2011 Apr;11(4):857-62.
Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Erasmus MC Rotterdam

Eligibility Criteria

Inclusion Criteria

  • •Age over 18 years of age
  • •\- On the active waiting list for liver transplantation
  • •\- Foreseen to be offered a donation after circulatory death (DCD) liver graft
  • •\- Written informed consent for this trial

Exclusion Criteria

  • •\- Contra\-indications for DCD liver graft
  • •\- Split or reduced liver grafts
  • •\- Technical contra\-indications to arterial reperfusion within 45 minutes (need for vascular reconstructions, jump grafting etc. during warm ischemic period)
  • •\- Multi\-organ transplantation
  • •\- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19Ischemic StrokeCovid19
NCT04895462Centre Hospitalier Universitaire Vaudois15,128
Unknown
Not Applicable
Intermittent Portal and Graft Purge in Living Donor Liver TransplantationHypotensionIschemia Reperfusion Injury
NCT02845154Mansoura University80
Recruiting
Not Applicable
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening IschemiaPeripheral Arterial DiseaseCritical Limb-Threatening IschemiaDiabetic Foot
NCT06277362EndoCore Lab s.r.l.50
Completed
Phase 4
Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent OcclusionPeripheral Vascular Disease
NCT02212626Flanders Medical Research Program30
Recruiting
Not Applicable
Revascularization for Symptomatic Non-acute Carotid Artery OcclusionNon-acute Carotid Artery Occlusion
NCT06303414Xuanwu Hospital, Beijing1,000